跳至主要内容
临床试验/NCT05759065
NCT05759065招募中不适用

A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2024年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
350
试验地点
2
主要终点
Insomnia severity index, ISI

研究概览

简要总结

The overall objective of this study is to conduct a randomized effectiveness-implementation trial to test the non-inferiority of tele-Brief Behavioral Treatment for Insomnia vs. tele-Cognitive-Behavioral Therapy for Insomnia among socioeconomically disadvantaged adults with insomnia in the primary care setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Meet clinical diagnostic criteria for insomnia
  • Insomnia severity score > 10
  • Eligible to receive care through publicly supported medical assistance, OR
  • Identify as race or ethnic minority
  • Has capacity for informed consent

排除标准

  • Untreated, current major depressive disorder
  • History of bipolar or psychosis
  • Active substance abuse or drug abuse
  • Excessive daytime sleepiness
  • Seizure within the past 1 year
  • Main sleep period outside of 8pm - 11am
  • Regular nightshift work
  • Untreated, previously diagnosed moderate to severe sleep apnea
  • Severe medical condition, which may require hospitalizations over the next 6 months
  • Active suicidal ideation, if elicited passively during screening
  • Pregnant or planning to become pregnant

结局指标

主要结局

Insomnia severity index, ISI

时间窗: 3 months

The Insomnia Severity Index is a 7-item self-report questionnaire assessing the nature, severity, and impact of insomnia in the last month. A 5-point Likert scale is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).

次要结局

  • Quality of Life and Symptoms - Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health(3-months)
  • Patient Health Questionnaire for depression (PHQ-8)(3-months)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Impairment, 8a(3-months)
  • Insomnia severity index, ISI(6- and 12-months)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance, 8b(3-months)
  • Diary-reported sleep efficiency(3-months)
  • Quality of Life and Symptoms - Generic-quality of life(3-months)
  • Generalized Anxiety Disorder (GAD-7)(3-months)
  • Diary reported sleep duration(3-months)
  • Number of participants with hypnotic use self-reported from the sleep diary(3-months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suzanne M. Bertisch, MD, MPH

Associate Physician, Clinical Director of Behavioral Sleep Medicine

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验